Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

NCT02883049

Conditions
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Burkitt Lymphoma, +18 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 239 locations
View Trial Details
Completed

A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies

NCT02651662

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana Farber/Harvard Cancer Center - PO box 849168 Boston, Massachusetts, United States
  • Harvard Medical School - Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Cancer & Hematology Centers of Western Michigan Grand Rapids, Michigan, United States
View all 30 locations
View Trial Details
Completed

The Role of 18F-FDG-PET for Staging and Prognostication

NCT04600804

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Ematologia Ospedale Vito Fazzi Lecce, Apulia, Italy
  • U.O.C Ematologia e Trapianto A.O. C. Panico Tricase, Apulia, Italy
  • U.O.Ematologia Ospedale Guglielmo da Saliceto Piacenza, Emilia-Romagna, Italy
  • Ematologia Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova Reggio Emilia, Emilia-Romagna, Italy
View all 34 locations
View Trial Details
Completed

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

NCT06113081

Conditions
Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +17 more
Locations
  • Clinica di Ematologia - AOU Ospedali Riuniti delle Marche Ancona, Italy
  • S.C. Ematologia e Trapianto emopoietico - A.O. S.Giuseppe Moscati Avellino, Italy
  • Clinica Dermatologia - A.O.U. Policlinico Consorziale Bari, Italy
  • U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy
View all 21 locations
View Trial Details
Completed

A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)

NCT05144841

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0229) Orange, California, United States
  • Innovative Clinical Research Institute ( Site 0202) Whittier, California, United States
  • Georgetown University Medical Center ( Site 0204) Washington D.C., District of Columbia, United States
  • Northside Hospital ( Site 0206) Atlanta, Georgia, United States
View all 71 locations
View Trial Details
Completed

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL

NCT02362997

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions